{"id":"pivmecillinam-hydrochloride-tablets","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal disturbances"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, resulting in the disruption of the cell wall synthesis and ultimately leading to bacterial cell death.","oneSentence":"Pivmecillinam hydrochloride is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:15.019Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Urinary tract infections"}]},"trialDetails":[{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT05545137","phase":"PHASE3","title":"Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection","status":"COMPLETED","sponsor":"Benova (Tianjin) Innovative medicine Research Co., Ltd.","startDate":"2022-09-29","conditions":"Uncomplicated Urinary Tract Infection","enrollment":299},{"nctId":"NCT05224401","phase":"PHASE3","title":"Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs","status":"RECRUITING","sponsor":"Lund University","startDate":"2023-05-29","conditions":"Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection","enrollment":330}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Selexid®"],"phase":"phase_3","status":"active","brandName":"Pivmecillinam hydrochloride tablets","genericName":"Pivmecillinam hydrochloride tablets","companyName":"Benova (Tianjin) Innovative medicine Research Co., Ltd.","companyId":"benova-tianjin-innovative-medicine-research-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pivmecillinam hydrochloride is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis. Used for Urinary tract infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}